Cardiometabolic Risk in Childhood Cancer Survivors Treated With Anthracyclines

Adult childhood cancer survivors treated with anthracyclines have elevated cardiometabolic risk, emphasizing the need for structured cardiac follow-up.

Read more: https://www.oncologynurseadvisor.com/news/anthracyclines-cardiometabolic-risk-childhood-cancer-survivors-treatment/